Publications:

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials.

Aids Research And Human Retroviruses

Lathouwers, Erkki E; Wong, Eric Y EY; Brown, Kimberley K; Baugh, Bryan B; Ghys, Anne A; Jezorwski, John J; Mohsine, El Ghazi EG; Van Landuyt, Erika E; Opsomer, Magda M; De Meyer, Sandra S; ,

Publication Date: 2020-01

Variant appearance in text: CD4: Q58Q

PubMed Link: 31516033

Variant Present in the following documents:

• Main text

View BVdb publication page